Neonatal alloimmune thrombocytopenia in Norway: poor detection rate with nonscreening versus a general screening programme

No abstract is available for this paper.

• Publication year

  2009

• Venue

  BJOG: an International Journal of Obstetrics and Gynaecology

• Publication date

  2009-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1471-0528.2008.02068.xPMID 19250370
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A prospective study of maternal anti-HPA 1a antibody level as a potential predictor of alloimmune thrombocytopenia in the newborn

  2008cited by this paper
• Cost‐effectiveness of antenatal screening for neonatal alloimmune thrombocytopenia

  2007cited by this paper
• A screening and intervention program aimed to reduce mortality and serious morbidity associated with severe neonatal alloimmune thrombocytopenia.

  2007cited by this paper
• Advances in the management of alloimmune thrombocytopenia

  2007cited by this paper
• Management of alloimmune thrombocytopenia

  2007cited by this paper
• Fetomaternal alloimmune thrombocytopenia: a literature review and statistical analysis

  2001cited by this paper

• Improving prediction of fetal/neonatal intracranial hemorrhage in HPA‐1a alloimmunized pregnancies to guide antenatal management: An observational cohort study

  2025cites this paper
• Effectiveness of antenatal intravenous immunoglobulin treatment in recurrent fetal and neonatal alloimmune thrombocytopenia

  2025cites this paper
• From concept to practice: Screening for fetal and neonatal alloimmune thrombocytopenia (FNAIT).

  2025cites this paper
• Clinical management in FNAIT - navigating a complicated landscape.

  2025cites this paper
• Screening of pregnant women for foetal neonatal alloimmune thrombocytopenia: A cost–utility analysis

  2024cites this paper
• What is the true story of FNAIT-induced complications?

  2023cites this paper
• Postnatal treatment for children with fetal and neonatal alloimmune thrombocytopenia: a multicentre, retrospective, cohort study.

  2022cites this paper
• Neonatal and fetal alloimmune thrombocytopenia

  2022cites this paper
• Approach to Neonatal Alloimmune Thrombocytopenia: The Perspective from a Transfusion Medicine Service

  2022cites this paper
• Prevention of Fetal/Neonatal Alloimmune Thrombocytopenia in Mice: Biochemical and Cell Biological Characterization of Isoforms of a Human Monoclonal Antibody

  2022cites this paper
• Next Generation Sequencing of Human Platelet Antigens for Routine Clinical Investigations and Donor Screening.

  2022cites this paper
• Platelet alloimmunization is associated with low grade chronic histiocytic intervillositis - A new link to a rare placental lesion?

  2021cites this paper
• Fetal and neonatal alloimmune thrombocytopenia: a late or missed diagnosis disease in fetal and perinatal health-care settings

  2020cites this paper
• Alloantibodies and Platelets

  2020cites this paper
• Fetal and neonatal alloimmune thrombocytopenia - The Norwegian management model.

  2019cites this paper
• Foetal and neonatal alloimmune thrombocytopenia: a review article and retrospective analysis of clinical and laboratory characteristics of patients in Slovenia between 1996 and 2016

  2019cites this paper
• Foetal and neonatal alloimmune thrombocytopenia - The role of the HLA-DRB3*01:01 allele for HPA-1a-immunisation and foetal/neonatal outcome.

  2019cites this paper
• Epidemiology and management of fetal and neonatal alloimmune thrombocytopenia.

  2019cites this paper
• Fetal and Neonatal Alloimmune Thrombocytopenia

  2018cites this paper
• Maternal HPA‐1a antibody level and its role in predicting the severity of Fetal/Neonatal Alloimmune Thrombocytopenia: a systematic review

  2018cites this paper
• Storage-Induced Platelet Apoptosis Is a Potential Risk Factor for Alloimmunization Upon Platelet Transfusion

  2018cites this paper
• Dual functionalization of magnetic nanoparticles by electroactive molecules and antibodies for platelet antigens detection.

  2017cites this paper
• Human platelet antigen antibody induction in uncomplicated pregnancy is associated with HLA sensitization

  2017cites this paper
• Fetal and neonatal alloimmune thrombocytopenia : towards implementation of screening in pregnancy

  2017cites this paper
• Recent advances in understanding the clinical relevance of antiplatelet alloantibodies.

  2017cites this paper
• Current perspectives on fetal and neonatal alloimmune thrombocytopenia – increasing clinical concerns and new treatment opportunities

  2017cites this paper
• Taking a wider view on fetal/neonatal alloimmune thrombocytopenia.

  2017cites this paper
• Maternal Anti-HLA Class I Antibodies in Connection with Pregnancy and Neonatal Thrombocytopenia – a Cause for Concern? Clinical Characteristics and Antibody Analysis of Retrospective and Prospective Populations

  2017cites this paper
• Platelet and Neutrophil Antigens

  2017cites this paper
• Special Disease Considerations in the Neonate

  2017cites this paper
• Fetal and neonatal alloimmune thrombocytopenia.

  2016cites this paper
• Neonatal outcome in alloimmune thrombocytopenia after maternal treatment with intravenous immunoglobulin.

  2015cites this paper
• Fetal/Neonatal Alloimmune Thrombocytopenia: Pathogenesis, Diagnostics and Prevention

  2015cites this paper
• Incidence and Consequences of Neonatal Alloimmune Thrombocytopenia: A Systematic Review

  2014cites this paper
• Neonatal pearls : safety and efficacy of medication use in fetus and neonate

  2013cites this paper
• Predicting risk severity and response of fetal neonatal alloimmune thrombocytopenia

  2013cites this paper
• Review of neonatal alloimmune thrombocytopenia

  2012cites this paper
• Thrombocytopenia in Pregnancy: Fetal and Neonatal Alloimmune Thrombocytopenia

  2012cites this paper
• Fetale und neonatale Alloimmunthrombozytopenie: Pathophysiologie, Diagnostik, Therapie

  2012cites this paper
• Noninvasive fetal genotyping of paternally inherited alleles

  2012cites this paper
• Delayed diagnosis of fetal and neonatal alloimmune thrombocytopenia: a cause of perinatal mortality and morbidity

  2012cites this paper
• Screening for Fetomaternal Alloimmune Thrombocytopenia

  2012cites this paper
• Føtal og neonatal alloimmun trombocytopeni er en mulig fatal tilstand

  2011cites this paper
• Neonatal alloimmune thrombocytopenia

  2011cites this paper
• Noninvasive fetal genotyping of human platelet antigen‐1a

  2011cites this paper
• Low‐avidity anti‐HPA‐1a alloantibodies are capable of antigen‐positive platelet destruction in the NOD/SCID mouse model of alloimmune thrombocytopenia

  2011cites this paper
• Specificity and HLA-restriction of CD4 T Cells Associated with Neonatal Alloimmune Thrombocytopenia

  2011cites this paper
• The incidence and outcomes of fetomaternal alloimmune thrombocytopenia: a UK national study using three data sources

  2011cites this paper
• A review of pathophysiology and current treatment for neonatal alloimmune thrombocytopenia (NAIT) and introducing the Australian NAIT registry

  2011cites this paper
• Maternal and Fetal Thrombocytopenia

  2011cites this paper
• Noninvasive fetal genotyping of human platelet

  2011cites this paper
• Screening in pregnancy for fetal or neonatal alloimmune thrombocytopenia: systematic review

  2010cites this paper
• Reconsidering fetal and neonatal alloimmune thrombocytopenia with a focus on screening and prevention

  2010cites this paper
• Neonatal Alloimmune Thrombocytopenia is Not What It was A Lesson Learned from a Large Prospective Screening and Intervention Program

  2009cites this paper
• Is it time to implement HPA-1 screening in pregnancy?

  2009cites this paper